Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction

This publication has 10 references indexed in Scilit:

• Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke
  Archives of Neurology, 2004
• Effect of atorvastatin on myocardial contractile reserve assessed by tissue doppler imaging in moderately hypercholesterolemic patients without heart disease
  The American Journal of Cardiology, 2003
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
  The Lancet, 2003
• The clinical use of HMG CoA‐reductase inhibitors and the associated depletion of coenzyme Q₁₀. A review of animal and human publications
  BioFactors, 2003
• Statins and chronic heart failure: do we need a large-scale outcome trial?
  Journal of the American College of Cardiology, 2002
• Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
  Current Medical Research and Opinion, 2002
• Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors
  Molecular Aspects of Medicine, 1997
• Recovery of load-induced left ventricular diastolic dysfunction by Coenzyme Q10: Echocardiographic study
  Molecular Aspects of Medicine, 1994
• Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
  International Journal of Clinical and Laboratory Research, 1994
• Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study
  The Journal of Clinical Pharmacology, 1993